Ranitidine (ATLANTIC BIOLOGICALS CORP.)
Welcome to the PulseAid listing for the Ranitidine drug offered from ATLANTIC BIOLOGICALS CORP.. This Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | ATLANTIC BIOLOGICALS CORP. |
NON-PROPRIETARY NAME: | Ranitidine |
SUBSTANCE NAME: | RANITIDINE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2009-09-19 |
END MARKETING DATE: | 0000-00-00 |
Ranitidine HUMAN PRESCRIPTION DRUG Details:
Item Description | Ranitidine from ATLANTIC BIOLOGICALS CORP. |
LABELER NAME: | ATLANTIC BIOLOGICALS CORP. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 15(mg/mL) |
START MARKETING DATE: | 2009-09-19 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 17856-0727_4ca3b7ed-3b83-4209-916d-99a17dfaab3e |
PRODUCT NDC: | 17856-0727 |
APPLICATION NUMBER: | ANDA077405 |
Other RANITIDINE Pharmaceutical Manufacturers / Labelers: